Keywords: biopartners, growth, hormone, 3-year, data, barr, switzerland-headquartered

Biopartners' growth hormone, 3-year data

Article | 29 September 2008

Barr, Switzerland-headquartered Biopartners GmbH presented three-year safety and efficacy trial data for its once-a-week, sustained-release recombinant human growth hormone LB03002 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing